Twist Bioscience to Present at 43rd Annual J.P. Morgan Healthcare Conference
Twist Bioscience to Present at 43rd Annual J.P. Morgan Healthcare Conference
Twist Bioscience is a leading and rapidly growing synthetic biology and genomics company that has developed a disruptive DNA synthesis platform to industrialize the engineering of biology. The core of the platform is a proprietary technology that pioneers a new method of manufacturing synthetic DNA by "writing" DNA on a silicon chip. Twist is leveraging its unique technology to manufacture a broad range of synthetic DNA-based products, including synthetic genes, tools for next-generation sequencing (NGS) preparation, and antibody libraries for drug discovery and development. Twist is also pursuing longer-term opportunities in digital data storage in DNA and biologics drug discovery. Twist makes products for use across many industries including healthcare, industrial chemicals, agriculture and academic research.SOUTH SAN FRANCISCO--(BUSINESS WIRE)--Dec. 19, 2024--Twist Bioscience Corporation (NASDAQ: TWST), a core mid-cap growth and value equity company in the life sciences segment of the health care sector, today announced that Emily M. Leproust, Ph.D., CEO and co-founder of Twist Bioscience, will present at the 43rd Annual J.P. Morgan Healthcare Conference on Monday, January 13, 2025 at 5:15 p.m. Pacific Time in San Francisco, California.
南舊金山--(美國商業資訊)--2024年12月19日--醫療保健行業生命科學領域的核心中型股增長和價值股票公司Twist Bioscience公司（納斯達克股票代碼：TWST）今天宣佈，Twist Bioscience首席執行官兼聯合創始人艾米麗·勒普魯斯特博士將於2025年1月13日星期一下午5點15分出席第43屆摩根大通醫療年度會議。加利福尼亞州舊金山時間。
The presentation will be webcast live and can be accessed by visiting the "Investor Calendar" page of the investor relations section of the company's website here. A replay of the presentation will be archived for a period of 30 days following the conclusion of the live events.
該演示將進行網絡直播，可通過此處訪問公司網站投資者關係部分的 「投資者日曆」 頁面進行訪問。演示的重播將在直播活動結束後存檔30天。
About Twist Bioscience Corporation
Twist 生物科學公司簡介
Twist Bioscience is a leading and rapidly growing synthetic biology and genomics company that has developed a disruptive DNA synthesis platform to industrialize the engineering of biology. The core of the platform is a proprietary technology that pioneers a new method of manufacturing synthetic DNA by "writing" DNA on a silicon chip. Twist is leveraging its unique technology to manufacture a broad range of synthetic DNA-based products, including synthetic genes, tools for next-generation sequencing (NGS) preparation, and antibody libraries for drug discovery and development. Twist is also pursuing longer-term opportunities in digital data storage in DNA and biologics drug discovery. Twist makes products for use across many industries including healthcare, industrial chemicals, agriculture and academic research.
Twist Bioscience是一家領先且發展迅速的合成生物學和基因組學公司，該公司開發了顛覆性的DNA合成平台，以實現生物工程的工業化。該平台的核心是一項專有技術，它開創了一種通過在硅芯片上 「寫入」 DNA來製造合成DNA的新方法。Twist 正在利用其獨特的技術製造各種基於 DNA 的合成產品，包括合成基因、下一代測序 (NGS) 製備工具以及用於藥物發現和開發的抗體庫。Twist還在DNA和生物製劑藥物發現中尋求數字數據存儲的長期機會。Twist 生產的產品適用於許多行業，包括醫療保健、工業化學品、農業和學術研究。
Follow us on LinkedIn | X | YouTube | Instagram
在領英上關注我們 | X | YouTube | Instagram
View source version on businesswire.com:
在 businesswire.com 上查看源版本：
For Investors:
Angela Bitting
SVP, Corporate Affairs
925-202-6211
abitting@twistbioscience.com
對於投資者：
安吉拉·比特廷
企業事務高級副總裁
925-202-6211
abitting@twistbioscience.com
For Media:
Amanda Houlihan
Communications Manager
774-265-5334
ahoulihan@twistbioscience.com
對於媒體：
阿曼達·霍利漢
傳播經理
774-265-5334
ahoulihan@twistbioscience.com
Source: Twist Bioscience Corporation
來源：Twist 生物科學公司
譯文內容由第三人軟體翻譯。
